Literature DB >> 25107431

Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.

Chuanming Zhang1, Xiuyu Xu1, Shuli Pu1, Shifeng Huang1, Jide Sun1, Shuangshuang Yang1, Liping Zhang2.   

Abstract

Carbapenem-resistant Escherichiacoli isolates harboring carbapenemases or combining an extended-spectrum β-lactamase (ESBL) enzyme with loss of porins present an increasingly urgent clinical danger. Combined resistance to aminoglycosides and fluoroquinolones in carbapeneme non-susceptible (CNS) isolates will inevitably create problems. In the current study, we characterized the carbapenemases and ESBLs, and the prevalence of quinolone resistance determinants and aminoglycoside resistance determinants in carbapenem-non-susceptible (CNS) E.coli isolates from a teaching hospital in Chongqing, Southwest China in 2012. Thirty non-duplicated CNS E.coli isolates were screened via antimicrobial susceptibility testing, and the drug resistance profiles of the 30 strains were analyzed. Carbapenemase genes blaKPC-2, ESBL genes including blaCTX-M-3, blaCTX-M-14, blaCTX-M-55 and blaTEM, ARD genes including aac(6')-Ib, armA and rmtB, and QRD genes including qnrA, qnrB, qnrC, qnrD, qnrS and aac(6')-Ib-cr were identified and clonal relatedness was investigated by pulsed-field gel electrophoresis. Of the 30 isolates, 2 (6.7%) harbored carbapenemase gene blaKPC-2; 29 (96.7%) carried ESBLs; 20 (66.7%) were QRD positive; and 11 (36.7%) were ARD positive. Between the two blaKPC-2 positive strains, one contained ESBL, QRD and ARD genes, while the other expressed ESBL genes but was negative for both QRD and ARD genes. Of the 29 ESBLs positive isolates, 2 (6.9%) were carbapenemase positive, 19 (65.5%) were QRD positive, and 11 (37.9%) were ARD positive. PFGE revealed genetic diversity among the 30 isolates, indicating that the high prevalence of CNS E. coli isolates was not caused by clonal dissemination. Production of ESBLs was associated with the carbapenem resistance and QRD genes were highly prevalent among the CNS E. coli isolates. Multiple resistant genes were co-expressed in the same isolates. This is the first report of a multidrug resistant carbapenem-non-susceptible E.coli co-harboring resistant determinants blaKPC-2, blaCTX-M-14, blaCTX-M-55, blaTEM, aac(6')-Ib-cr, qnrB, aac(6')-Ib and rmtB from Chongqing, mainland China.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Aminoglycosides; Carbapenem-non-susceptible; Carbapenemases; Escherichia coli; Extended spectrum β-lactamases; Fluoroquinolones

Mesh:

Substances:

Year:  2014        PMID: 25107431     DOI: 10.1016/j.meegid.2014.07.031

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  14 in total

1.  Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China.

Authors:  F Zhang; D Zhu; L Xie; X Guo; Y Ni; J Sun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-11       Impact factor: 3.267

2.  Emergence of KPC-2-producing Escherichia coli isolates in an urban river in Harbin, China.

Authors:  Guofeng Xu; Yue Jiang; Wei An; Hongdong Wang; Xiuying Zhang
Journal:  World J Microbiol Biotechnol       Date:  2015-07-07       Impact factor: 3.312

3.  Epidemiological and clinical features for cefepime heteroresistant Escherichia coli infections in Southwest China.

Authors:  W Ma; J Sun; S Yang; L Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-27       Impact factor: 3.267

4.  Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial -Escherichia coli infection in China.

Authors:  Huiqing Shi; Fengjun Sun; Jianhong Chen; Qianyi Ou; Wei Feng; Xiaolan Yong; Peiyuan Xia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-01-16       Impact factor: 3.944

5.  A locked nucleic acid (LNA)-based real-time PCR assay for the rapid detection of multiple bacterial antibiotic resistance genes directly from positive blood culture.

Authors:  Lingxiang Zhu; Dingxia Shen; Qiming Zhou; Zexia Li; Xiangdong Fang; Quan-Zhen Li
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

6.  Multidrug Resistance Mechanisms of Carbapenem Resistant Klebsiella pneumoniae Strains Isolated in Chongqing, China.

Authors:  Jinrong Yan; Shuli Pu; Xiaojiong Jia; Xiuyu Xu; Shuangshuang Yang; Jing Shi; Shan Sun; Liping Zhang
Journal:  Ann Lab Med       Date:  2017-09       Impact factor: 3.464

7.  Carbapenem-Resistant E. cloacae in Southwest China: Molecular Analysis of Resistance and Risk Factors for Infections Caused by NDM-1-Producers.

Authors:  Xiaojiong Jia; Wei Dai; Weijia Ma; Jinrong Yan; Jianchun He; Shuang Li; Congya Li; Shuangshuang Yang; Xiuyu Xu; Shan Sun; Jing Shi; Liping Zhang
Journal:  Front Microbiol       Date:  2018-04-04       Impact factor: 5.640

8.  Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms.

Authors:  Kunling Sun; Xiuyu Xu; Jinrong Yan; Liping Zhang
Journal:  Ann Lab Med       Date:  2017-07       Impact factor: 3.464

9.  Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131.

Authors:  Teemu Kallonen; Hayley J Brodrick; Simon R Harris; Jukka Corander; Nicholas M Brown; Veronique Martin; Sharon J Peacock; Julian Parkhill
Journal:  Genome Res       Date:  2017-07-18       Impact factor: 9.043

10.  Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia.

Authors:  Muhammad Yasir; Abeer M Ajlan; Shazi Shakil; Asif A Jiman-Fatani; Saad B Almasaudi; Muhammad Farman; Zainah M Baazeem; Rnda Baabdullah; Maha Alawi; Nabeela Al-Abdullah; Nashat A Ismaeel; Hani A Shukri; Esam I Azhar
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.